-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-203-adhd-disposition-comments.pdf
January 01, 2018 - TEP Reviewer #4 Introduction Page 9, line 43: I would add "frequency of stimulant
prescription renewals
-
psnet.ahrq.gov/perspective/role-graduate-medical-education-gme-improving-patient-safety
February 01, 2010 - The Role of Graduate Medical Education (GME) in Improving Patient Safety
Arpana R. Vidyarthi, MD; Robert B. Baron, MD, MS | February 1, 2010
Also Read a Conversation
View more articles from the same authors.
Citation Text:
Baron RB, Vidyarthi A. The Role of Gra…
-
psnet.ahrq.gov/perspective/conversation-withthomas-j-nasca-md
February 01, 2010 - In Conversation with…Thomas J. Nasca, MD
February 1, 2010
Also Read an Essay
Citation Text:
In Conversation with…Thomas J. Nasca, MD. PSNet [internet]. Rockville (MD): Agency for Healthcare Research and Quality, US Department of Health and Human Services. 2010.
…
-
cds.ahrq.gov/sites/default/files/cds/artifact/76/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making.pdf
April 01, 2021 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Shared Decision Making (2021)
1
Implementation Guide
CMS’s Million Hearts® Model Longitudinal
ASCVD Risk Assessment Tool for Shared
Decision Making
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
www.ah…
-
cds.ahrq.gov/sites/default/files/cds/artifact/81/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%2010-Year%20ASCVD%20Risk.pdf
January 01, 2010 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Updated 10-Year ASCVD Risk (April 2021)
1
Implementation Guide
CMS’s Million Hearts® Model Longitudinal
ASCVD Risk Assessment Tool for Updated 10-
Year ASCVD Risk
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD…
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/2024_CDS_Connect_IG_Aspirin_Therapy.pdf
January 01, 2024 - Implementation Guide: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication
Implementation Guide
US Preventive Services Task Force Aspirin Use to Prevent
Cardiovascular Disease: Preventive Medication
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
www.ahrq.gov
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-jaw-rapid-response.pdf
May 01, 2025 - treatment
and is consistently higher in patients receiving IV BPs.21
Besides medication type, duration, prescription … outline
specific considerations of before and after antiresorptive treatment, including length of
prescription … care providers should refer patients to their medical
physicians regarding antiresorptive medication prescriptions
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs025405-schmajuk-final-report-2024.pdf
January 01, 2024 - Effect of Integrating Access to a Prescription Drug Monitoring Program Within
the Electronic Health
-
effectivehealthcare.ahrq.gov/system/files/docs/headaches-pregnancy-topic-brief.pdf
January 01, 2019 - magnesium or
medication* or narcotic* or nonpharmacolog* or non-pharmacolog* or nonprescription or
non-prescription
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017163-baker-final-report-2011.pdf
January 01, 2011 - Performance decreased for two other measures during Phase 2: 1)
prescription of anticoagulants for patients
-
digital.ahrq.gov/sites/default/files/docs/publication/r03hs018795-balasubramanian-final-report-2012.pdf
January 01, 2012 - Indeed we view the framework of this paper not as a strict prescription that dictates
what practices
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/introduction.ppt
January 01, 2010 - Section 1013 of the 2003 Medicare Prescription Drug, Improvement, and Modernization Act authorized the
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-evidence-communication_executive.pdf
November 01, 2013 - Communicating uncertainties
about prescription drugs to the public: a national randomized
trial.
-
hcup-us.ahrq.gov/reports/methods/MS2022-03-PopulationReport.pdf
December 15, 2022 - regional
Diseases and Health:
Mental illness and the use of alcohol, tobacco, marijuana, cocaine, prescription-type
-
hcup-us.ahrq.gov/reports/methods/2020-02.pdf
January 01, 2020 - regional
Diseases and Health:
Mental illness and the use of alcohol, tobacco, marijuana, cocaine, prescription-type
-
digital.ahrq.gov/sites/default/files/docs/citation/u18hs027099-malone-final-report-2022.pdf
January 01, 2022 - providers work together to
determine the most appropriate actions to mitigate potential harm from the prescription
-
hcup-us.ahrq.gov/reports/methods/MS-2021-04-PopulationReport.pdf
January 01, 2021 - regional
Diseases and Health:
Mental illness and the use of alcohol, tobacco, marijuana, cocaine, prescription-type
-
www.ahrq.gov/sites/default/files/wysiwyg/hai/abate/introduction/scientific-rationale.pdf
March 01, 2022 - acquisition and infection by 40–50 percent in
high-risk settings such as ICUs.12,46,49-51
Mupirocin is a prescription
-
www.ahrq.gov/sites/default/files/2024-12/kmetik-otoole-report.pdf
January 01, 2024 - To illustrate with a measure regarding the prescription of a medication, a
clinical contraindication
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/quality-improvement/improvement-guide/4-approach-qi-process/cahps-section-4-ways-to-approach-qi-process.pdf
May 17, 2017 - Ways to Approach the Quality Improvement Process
May 2017 4-16
prescription, fill, and dispense.